Hhlr Advisors, Ltd. Legend Biotech Corp Transaction History
Hhlr Advisors, Ltd.
- $2.42 Billion
- Q2 2025
A detailed history of Hhlr Advisors, Ltd. transactions in Legend Biotech Corp stock. As of the latest transaction made, Hhlr Advisors, Ltd. holds 5,984,550 shares of LEGN stock, worth $221 Million. This represents 8.76% of its overall portfolio holdings.
Number of Shares
5,984,550
Previous 5,984,550
-0.0%
Holding current value
$221 Million
Previous $203 Million
4.6%
% of portfolio
8.76%
Previous 6.23%
Shares
11 transactions
Others Institutions Holding LEGN
# of Institutions
237Shares Held
60MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$256 Million1.21% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$212 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$140 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$110 Million2.42% of portfolio
-
Braidwell LP Stamford, CT2.54MShares$94 Million5.53% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...